Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection

Clinical trial NCT06541327 · RECRUITING

Trial details

NCT number: NCT06541327
Sponsor: Ruijin Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Lymphoma, Non-Hodgkin

Start date: 2024-05-15
Primary completion: 2040-12-31
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.